Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Z Punthakee
  • J Bosch
  • G Dagenais
  • Ricardo Gredilla Diaz
  • R Holman
  • J L Probstfield
  • A Ramachandran
  • M C Riddle
  • L E Rydén
  • B Zinman
  • R Afzal
  • S Yusuf
  • H C Gerstein
  • TIDE Trial Investigators
  • Torp-Pedersen, Christian Tobias
AIMS/OBJECTIVE: Conflicting data regarding cardiovascular effects of thiazolidinediones (TZDs) and extra-skeletal effects of vitamin D supported the need for a definitive trial. The Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) trial aimed to assess the effects of TZDs (rosiglitazone and pioglitazone) on cardiovascular outcomes and the effects of vitamin D (cholecalciferol) on cancers and mortality.
OriginalsprogEngelsk
TidsskriftDiabetologia
Vol/bind55
Udgave nummer1
Sider (fra-til)36-45
Antal sider10
ISSN0012-186X
DOI
StatusUdgivet - jan. 2012

ID: 48592277